All the mentioned reports suggest that PI3K/Akt signaling plays a significant role in post-infarction myocardial hypertrophy, and that adequate regulation of this pathway could potentially be an important therapeutic target to reduce the incidence of HF. This evidence concerns the gene AKT1 and cardiac hypertrophy.